In one paragraphArticle in Microbiology resource announcements, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
5 authors.
Brandi L CobeDepartment of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois, USA.
Egon A OzerDivision of Infectious Diseases, Department of Medicine, Northwestern University Medical School, Chicago, Illinois, USA.ORCID 0000-0002-7131-3691 Sophia H NozickDepartment of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois, USA.
Alan R HauserDepartment of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois, USA.ORCID 0000-0003-4596-7939 Nicholas P CianciottoDepartment of Microbiology-Immunology, Northwestern University Medical School, Chicago, Illinois, USA.ORCID 0000-0002-9572-8322 Funding
Technology CoreU19AI135964 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LUIS A. Nunes AMARAL · 2018 to 2026
$24.7MCELLULAR &MOLECULAR BASIS OF DISEASE TRAINING PROGRAMT32GM008061 · NIGMS · NORTHWESTERN UNIVERSITY · PI CARTHEW, RICHARD W. · 1985 to 2022
$17.1MStenotrophomonas maltophilia TfcA and TfcB: Antibacterial T4SS effectors from an emerging human pathogenR21AI171325 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CIANCIOTTO, NICHOLAS P · 2023 to 2024
$420kStenotrophomonas Maltophilia Type IV Secretion: Modulator of Both Host-Cell Apoptosis and Interbacterial KillingR21AI139596 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CIANCIOTTO, NICHOLAS P · 2019 to 2020
$417kNational Institute of Allergy and Infectious Diseases AI139596,AI171325NIAID NIH HHS R21 AI139596NIAID NIH HHS R21 AI171325NIAID NIH HHS U19 AI135964NIGMS NIH HHS GM08061NIGMS NIH HHS T32 GM008061
6 · The paper itselfAbstract
We report the draft genome sequences of
Indexed as
StenotrophomonasStenotrophomonas maltophiliaStenotrophomonas pavanii
Identifiers
PMID40586539
PMCPMC12352037
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390